Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma

Overview of attention for article published in Frontiers in Pharmacology, April 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 27,119 followers.

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma https://t.co/sA6hJwnBA4 https://t.co/zr369oLGL0

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma https://t.co/qpg7wCeZiZ https://t.co/NRsj5WYQxb

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma https://t.co/COhRDq7OYD https://t.co/wiCpTc0gFP

RT @FrontPharmacol: New Research: Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellul…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.